Date: March 13, 2026
Reporter: Dalena Reporters
Canadian health authorities have launched an investigation after two people died following plasma donations at private clinics in Winnipeg, raising national concerns about the safety of paid plasma collection in the country.
According to reports, the deaths occurred months apart at two plasma collection centres operated by the Spanish pharmaceutical company Grifols. One death reportedly happened in October 2025, while another occurred in January 2026, prompting federal health officials to review the incidents.
Federal Health Agency Investigating
Health Canada confirmed it is reviewing the circumstances surrounding the fatalities, though officials say there is no confirmed link yet between the deaths and the plasma donation procedure.
The agency noted that plasma donation is generally considered safe but said investigations are ongoing to determine whether any medical complications or procedural issues may have contributed to the incidents.
One of the deceased donors was reportedly a 22-year-old international student, whose death has drawn public sympathy and renewed scrutiny over the operations of paid plasma clinics in Canada.
Concerns Over Private Plasma Collection
The deaths have intensified debate over for-profit plasma donation centres, where donors are paid for each plasma donation. At some facilities, donors can receive up to around $100 per session, with the option to donate as often as twice a week.
Health advocates argue that paying donors may encourage people to donate too frequently, raising potential safety concerns. Critics are also calling for stronger oversight and transparency in the plasma collection industry.
Advocacy groups in Canada are now pushing for an independent investigation or public inquest into the deaths to ensure accountability and prevent similar incidents in the future.
Company Denies Direct Connection
Grifols, the company operating the clinics involved, said it has no evidence linking the deaths directly to plasma donation and maintains that its centres follow strict medical screening and operational procedures.
The company added that all donors undergo health assessments and physical examinations before being approved to donate plasma.
Growing National Debate
The incident has revived concerns about Canada’s blood and plasma system, particularly as the country relies heavily on plasma-based medicines used to treat conditions such as immune disorders, burns, and haemophilia.
Experts warn that while fatal complications from plasma donation are extremely rare, the deaths highlight the need for strong regulatory oversight and transparent investigations.
As federal health officials continue their review, the outcome could influence future policies regarding paid plasma donation centres across Canada.